Updates ·
Health notices · Sunday 9 August
3 notices from the agencies today, in plain words, each with the original linked.
Emergency authorization for wound spray to help prevent screwworm infestations
Food and Drug Administration (FDA) · Announcement
The FDA has issued an Emergency Use Authorization (EUA) for CLiK Extra (dicyclanil topical suspension) wound spray to help prevent New World screwworm (NWS) infestations (myiasis) in several animals, including sheep, cattle, goats, swine, and certain captive wildlife.
The spray is authorized only for prevention of NWS myiasis associated with wounds, birth, and after surgical or husbandry procedures (for example, dehorning, ear tagging, castration, tail docking, shearing), when applied at the time of wound appearance or creation.
It works as an insect growth regulator, disrupting larvae development before they can cause tissue damage. If a wound is already infested, or if an infestation develops after using the product, contact a veterinarian to discuss treatment options.
What to do
- If a wound is already infested, or if an infestation develops after administering the product, contact a veterinarian to discuss treatment options.
Morphine sulfate injection lot recalled due to label mix-up
FDA-SAFETY
If you have received Morphine Sulfate Injection USP, Simplist® 2 mg/1 mL from the recalled lot (lot 6402820), the syringe label may have been mixed up.
The recalled MicroVault labeled as morphine may contain a prefilled syringe of Dilaudid (hydromorphone HCl) 0.5 mg/0.5 mL. This mix-up can cause serious harm, including life-threatening respiratory depression and death.
The recall is being conducted “to the user level” and involves a nationwide distribution. Health care facilities should stop using and return affected units.
What to do
- If you have received this recalled lot, contact your physician or health care provider if you have experienced any problems that may be related to receiving this drug product.
Domperidone contraindicated in phaeochromocytoma due to severe hypertension risk
Medicines and Healthcare products Regulatory Agency (MHRA) · Safety
If you have confirmed or suspected phaeochromocytoma (a rare adrenal-gland tumour), domperidone should not be used because it can be linked to episodes of severe high blood pressure.
If you already take domperidone and you have phaeochromocytoma, stop taking it immediately and speak to your doctor or pharmacist about alternative treatment.
What to do
- Stop taking domperidone immediately if you have been diagnosed with phaeochromocytoma.
- Speak to your doctor or pharmacist about alternative treatment options.
- Seek medical attention immediately if you experience symptoms of severe high blood pressure.